Valuation
Is the price right?3/3 inputs reported · High confidence
Weaker than most peers on:
- ▼ EBITDA yield
Behind the score
Sector-normalized EBITDA, earnings, and free cash flow yields.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Oct 8, 2026
3/3 inputs reported · High confidence
Weaker than most peers on:
Sector-normalized EBITDA, earnings, and free cash flow yields.
2/3 inputs reported · Partial data
Stronger than most peers on:
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
3/3 inputs reported · High confidence
Weaker than most peers on:
Return on invested capital, operating margin, and return on assets.
3/3 inputs reported · High confidence
Stronger than most peers on:
Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 90.4M USD | 95.4M USD | +5.5% |
| Net income (12 months) | 561,000 USD | 532,000 USD | −5.2% |
| Operating margin | -1.8% | -1.9% | −0.1 pts |
| Free cash flow (12 months) | 19.2M USD | 17.5M USD | −8.8% |
| Cash | 41.3M USD | 47.5M USD | +15.0% |
| Shares outstanding | 34.5M | 34.7M | +0.5% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Medical Devices are near the bottom of their range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Gross margin | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% | ▲ 2.8 pts |
| Operating margin | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% | ▲ 34 pts |
| Net margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% | ▲ 74 pts |
| Return on assets (ROA) | -77.4% | -204.4% | -123.5% | -34.5% | 2.2% | ▲ 37 pts |
| Return on equity (ROE) | -214.6% | — | -302.2% | -38.4% | 2.4% | ▲ 41 pts |
| Free cash flow margin | -639.9% | -925.3% | -1516.2% | -51.7% | 24.6% | ▲ 76 pts |
| Current ratio | 5.23× | 1.10× | 2.26× | 12.01× | 10.92× | ▼ 9.1% |
| Quick ratio | 4.99× | 0.96× | 2.06× | 10.88× | 9.98× | ▼ 8.2% |
| Debt to equity | 1.48× | — | 0.67× | 0.00× | — | — |
Price history is added with the daily price update and will appear after the next one.